Archives
UC D br FC CD Biolegend A br
UC7-13D5
FC: CD3
Biolegend
17A2
Biolegend
RM4-5
eBioscience
N418
Biolegend
HK1.4
Biolegend
UC3-10A6
FC: IFN-g
BD Bioscience
XMG1.2
FC: TNFa
eBioscience
MP6-XT22
(Continued on next page)
Continued
REAGENT or RESOURCE
SOURCE
IDENTIFIER
Biolegend
IM7
eBioscience
LG.3A10
FC: CD69
Biolegend
FC: PD-1
Biolegend
eBioscience
FC: RORgt
eBioscience
FC: PLZF
eBioscience
Mags.21F7
BD Bioscience
B56
Dr. Robert Tigelaar and Julia Lewis (Yale University, CT)
17D1
IHC: Purified Rat Anti-Mouse Ly-6G
BD Pharmingen
1A8
IHC: Mouse mAb against human TCRd
Santa Cruz
H-41
Bacterial and Virus Strains
Adenovirus (Sftpc-Cre)
Viral Vector Core, University of Iowa
Ad5mSPC-Cre
Chemicals, Peptides, and Recombinant Proteins
Recombinant mouse IL-1b
Recombinant mouse IL-23
Recombinant mouse IL-22
Recombinant human amphiregulin
Lipopolysaccharide from E. coli O111:B4 (LPS)
Invivogen
tlrl-eblps
Peptidoglycan from S. aureus (PGN)
Invivogen
tlrl-pgns2
Critical Commercial Assays
Mouse IL-17A (homodimer) ELISA
CellTiter-Glo Luminescent Cell Viability Assay
Deposited Data
RNA-seq
16S sequencing
Experimental Models: Organisms/Strains
Jackson Laboratory
000664
Jackson Laboratory
009088
Jackson Laboratory, crossed to KP mice
026175
Jackson Laboratory, crossed to KP mice
002014
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Tyler Jacks ([email protected]).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals and In Vivo Procedures
mice were used in all experimental groups in all mouse experiments. In most experiments, KP mice were infected with 2.5x108 pla-que-forming units (pfu) of Sftpc-Cre expressing adenovirus (Viral Vector Core, University of Iowa) or 30,000 transforming units of len-tiviral Pimozide co-expressing Cre and specific sgRNAs through intratracheal instillation between 8-12 weeks of age to initiate tumors, as previously described (DuPage et al., 2009). In the bacterial inoculation experiment, KP mice were infected with 2.0x108 pfu of Sftpc-Cre expressing adenovirus. Mice were randomized before treatments. For antibiotic treatment, mice were given a cocktail of ampicillin (1g/L, American Bioanalytical), neomycin trisulfate (1g/L, Sigma), metronidazole (1g/L, Sigma) and vancomycin (500 mg/L, Goldbio) (4Abx) or metronidazole alone in drinking water at indicated time points. For antibody-mediated depletion ex-periments, animals were treated every 2-3 days with i.p. injection of monoclonal antibodies (200 mg/mouse) directed against gd-TCR (UC7-13D5, BioXCell; or GL3, purified from the hybridoma generously provided by Dr. O’Brien, National Jewish Health, Denver) or IL-17A (17F3, BioXCell), and their isotype controls (BioXCell). For in vivo stimulation of gd T cells in the lung, recombinant mouse IL-1b (R&D Systems, 100 ng/mouse) plus IL-23 (R&D Systems, 100 ng/mouse), or LPS (Lipopolysaccharide from E. coli O111:B4, Invivogen, 2 mg/mouse) plus PGN (Peptidoglycan from S. aureus, Invivogen, 5 mg/mouse) were administered intratracheally to wild-type C57BL/6J mice. For bacterial inoculation experiment, 14 bacterial strains were isolated and cultured from late-stage lung tumors from SPF mice. They were mixed and intratracheally administered at a total dose of 107 CFU to a separate cohort of KP mice 3.5 weeks post tumor initiation. For bone marrow chimera experiments, KP mice on the CD45.1 background were irradiated with a Gammacell-40 Irradiator (5.5 Gy x 2, 3.5 hours apart), and then transplanted with bone marrow collected from wild-type or Myd88 knockout (Jackson Laboratory) donors on the CD45.2 background. Seven weeks post bone marrow reconstitution, mice were infected with 2.5x108 pfu of Sftpc-Cre expressing adenovirus for tumor initiation. All studies were performed under a Massa-chusetts Institute of Technology Committee on Animal Care-approved animal protocol, or an ICUC approved animal study protocol at NIAID, NIH (LSB-1E and LSB-4E). Mice were assessed for morbidity according to MIT Division of Comparative Medicine guidelines and were humanely euthanized when ill.